Evaluation of the Effect of Low Level Laser Therapy on Crestal Bone Changes and Secondary Stability Around Delayed Implant

October 29, 2024 updated by: Lina Amr Talaat

" EVALUATION OF LOW INTENSITY LASER BIOMODULATORY EFFECT ON CRESTAL BONE CHANGES AROUND DELAYED IMPLANTS " A Randomized Controlled Clinical Trial

Although implant survival and success rates are prominent, there is still progress to be made in both survival and success rates, as well as in improving implant stability at implant placement in order to accomplish osseo-integration without significantly reducing peri-implant marginal bone. Low-level laser therapy (LLLT) has been postulated in studies looking into enhancing implant stability. Understanding the effect of LLLT on bone remodeling is crucial to knowing whether LLLT will enhance implant-bone interaction. LLLT prompts vascularization of the bone defect site and also stimulates osteoblasts, which can facilitate recovery of hard tissue. In addition, it has been recently reported that LLLT has positive effects in ossification and osseo-integration of dental implants.

Study Overview

Detailed Description

This study will be conducted to evaluate the effects of LLLT on the crestal bone changes around dental implants.

Study Setting Faculty of Dentistry, Ain Shams University. Sample size : 24 patients are eligible to the study.

•statistical analysis : Categorical data will be represented as frequency (n) and percentage (%) and will be analyzed using chi square test. Numerical data will be explored for normality by checking the data distribution, calculating the mean and median values and using Kolmogorov-Smirnov and Shapiro-Wilk tests. If the data was found to be normal, it will be presented as mean and standard deviation values and independent t-test will be used for intergroup comparison. If the assumption of normality is violated, the data will be presented as median and range values and intergroup comparison will be done using Mann-Whitney U test and Freidman's test. The significance level will be set at P ≤0.05 for all tests. Statistical analysis will be performed with IBM® SPSS® Statistics Version 25 for Windows.

Inclusion Criteria:

  1. Healthy adult patients as evidenced by Burkett's oral medicine health history questionnaire (18).
  2. Both genders.
  3. Age from 20 -50 years old.
  4. History of extraction< 6 months.
  5. Site specific upper esthetic zone from right second premolar to left second premolar.

Exclusion criteria:

  1. Patients taking drugs affecting bone metabolism for the past six months. eg. cyclosporine, methotrexate, synthetic retinoids
  2. Smokers
  3. Pregnancy and lactation
  4. Patients with periodontal or periapical infections.
  5. Vertical and horizontal root fracture
  6. Mentally retarded Patients.

Study procedures:

  1. Randomization and allocation concealment technique: Patients will be randomly allocated according to predetermined computer-generated randomization using www.Randomizer.org
  2. Details of the interventions, testing and follow up:

    • Group A test:

      10 patients will be subjected to delayed implant placement with Laser Biostimulation with Low Level Laser Therapy.

    • Group B control:

      10 patients will be subjected to conventional delayed implant placement.

Study protocol and surgical steps

  1. Radiographs will be taken from all patients after an intraoral examination.
  2. Following the mucosal incision, the mucoperiosteal flap will be elevated.
  3. Drilling will be performed at 900 rpm in both groups. All implants will be placed with the same torque (60 rpm) by the same surgeon (15).
  4. All patients receive oral hygiene and post-operative care instructions. Group A: implant placement followed by laser bio- stimulation. Group B: implant placement without further intervention.

Low Level Laser Therapy Protocol:

Group A ( Test ):

In our study we applied a red diode laser (SmartM, Lasotronix, Poland) at 635 nm wavelength with biomodulating handpiece with following set parameters for the first session of LLLT output power: 100mW handpiece diameter: 2mm spot area: 0.0314cm2 average power density: 199.04mW/cm2 continuous mode, dose: 4J per point (16J/cm2) time: 10 sec per point, 4 points (irradiation on a buccal,lingual,mesial and distal side of the alveolus/implant), and total energy per session 16J Four irradiation sessions were provided with first therapy administered immediately following osteotomy and prior to implant placement and then immediately after implant placement , and then repeated on third day, seventh day, and fourteenth day after implant placement.

Parameters for the following sessions of LLLT :

output power: 100mW handpiece diameter: 8mm spot area: 0.5024cm2 average power density: 199.04mW/cm2 continuous mode, dose: 4J per point (16J/cm2) time: 10 sec per point, 4 points (irradiation on a buccal, lingual, mesial and distal side of the alveolus/implant), and total energy per session 16J

Group B (Control):

The same procedure was followed without laser application in this group.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 4531
        • Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1- Healthy adult patients as evidenced by Burkett's oral medicine health history questionnaire (18).

    2- Both genders. 3- Age from 20 -50 years old. 4- History of extraction< 6 months. 5- Site specific upper esthetic zone from right second premolar to left second premolar.

Exclusion criteria:

  1. Patients taking drugs affecting bone metabolism for the past six months. eg. cyclosporine, methotrexate, synthetic retinoids
  2. Smokers
  3. Pregnancy and lactation
  4. Patients with periodontal or periapical infections.
  5. Vertical and horizontal root fracture
  6. Mentally retarded Patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control group
Delayed implant placement restoring missed tooth
Active Comparator: Study group
Laser biomodulation with low level laser therapy around delayed implant

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Radiographic evaluation of crestal bone changes
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Evaluation of the secondary implant stability using implant stability quotient ( ISQ ) in response to LLLT.
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Lina Amr Elsayed, Ain Shams University
  • Principal Investigator: Lina Amr Elsayed, Master candidate, Ain Shams University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2023

Primary Completion (Actual)

May 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

October 29, 2024

First Submitted That Met QC Criteria

October 29, 2024

First Posted (Actual)

October 30, 2024

Study Record Updates

Last Update Posted (Actual)

October 30, 2024

Last Update Submitted That Met QC Criteria

October 29, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 1211

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laser Effect Around Dental Implant

Clinical Trials on implant placement and low level laser therapy

Subscribe